Success Story: NAILG Accelerates NIW Approval for Clinical Researcher Transforming Public Health – 28 Days to Success

Client’s Testimonial:

“The team was very professional in writing all my letters and testimonials. They provided all drafts and responses within the time frame mentioned. Everything was explained very well with detailed requirements and easy-to-understand terms, which made it easy to arrange for the required documents. The team was very prompt in answering the silliest of my questions. I am very thankful for the team to help me achieve this milestone in my career.”

On January 31^st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher IV in the field of Clinical Research (Approval Notice).

General Field: Clinical Research

Position at the Time of Case Filing: Researcher IV

Country of Origin: India

State of Residence at the Time of Filing: Mississippi

Approval Notice Date: January 31^st, 2025

Processing Time: 28 days (Premium Processing Requested)

Case Summary:

An exceptional researcher specializing in clinical research has achieved approval of her EB-2 NIW (National Interest Waiver) petition with the assistance of the North America Immigration Law Group (NAILG). Her work centers on advancing biostatistical and epidemiological methodologies to analyze large-scale health data and to develop innovative diagnostic and therapeutic frameworks that address infectious diseases, cancer, and metabolic disorders.

At the time of filing, she was serving as a research scientist applying advanced statistical and computational methods to clinical trials and health data interpretation. Her proposed endeavor holds clear substantial merit and national importance, as it supports national efforts to reduce disease burden, improve early diagnosis, and enhance patient outcomes across healthcare systems in the United States.

Her extensive contributions to the field are reflected in her publications and collaborative research record. She has authored 13 peer-reviewed journal articles and 4 abstracts, many of which stem from participation in prestigious research consortia such as the Major Extremity Trauma Research Consortium (METRC) and the Program of Randomized Trials to Evaluate Pre-operative Antiseptic Skin Solutions in Orthopedic Trauma (PREP-IT). Her studies have appeared in highly regarded journals, and collectively, her independent and collaborative publications have been cited 130 times, showcasing the influence and applicability of her work within the clinical and biomedical communities. Her analyses have informed the development of guidelines for infection prevention, blood clot management, and trauma care, all of which directly improve clinical practice and patient safety.

As one expert stated, “In summary, [Client] provides crucial information for improving the quality of life and functional outcomes for individuals with high-energy injuries to their extremities.” This testimonial reflects not only the rigor of her research but also its practical significance in enhancing healthcare outcomes and shaping medical standards.

NAILG is honored to have supported this talented researcher in securing NIW approval. Her success highlights the impact of her data-driven work in advancing evidence-based medicine and reinforces NAILG’s commitment to helping outstanding scientists and clinicians continue making meaningful contributions to public health and medical innovation in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.